In biomedical research, data should be treated as first-class corporate assets--they were expensive to create, they are expensive to maintain, and they have future business value. The petabytes of data generated for one NME could have high impact when combined with other data across therapeutic areas, informing new discoveries and accelerating new drugs to market. However, data are often stored in share folders where they are siloed and lie fallow because they are nearly impossible to find and reuse. Fractured data environments inhibit analytical strategies, decrease security, and ultimately place a drag on ROI. Like fighter jets flying in formation, the power and value of scientific data is enhanced when data “fly in formation.” In this presentation, the authors challenge the status quo and ask the audience to imagine a future where precision informatics tools are deployed to manage laboratory operations and integrate legacy data with incoming data across global sites and therapeutic areas. They will discuss how the cloud and the edge, with IoT, artificial intelligence, and machine learning, are transforming research, enabling science, accelerating discovery, and improving ROI.
1. What do we mean by, Data 360o and Situational Awareness? Why are these concepts so important to science and ROI? With these concepts in mind, the attendees will learn about considerations and common pitfalls to avoid when evaluating informatics technologies.
2. Why is data aggregation and data harmonization so important and what technology tools can help implement these related concepts? As we consider data aggregation, what is a things-platform, and how will these platforms be integral components in the future lab.
3. Peering into the future, the authors will discuss emergent technologies and how they will be soon be transforming research workflows.